O	O	O	0	3	The	The	B-NP	DT	O	6	NMOD	O
O	O	O	4	9	human	human	I-NP	JJ	B-cell_line	6	NMOD	B-cell_line
O	O	O	10	24	myelomonocytic	myelomonocytic	I-NP	JJ	I-cell_line	6	NMOD	I-cell_line
O	O	O	25	29	cell	cell	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	O	30	34	line	line	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	O	35	36	U	U	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	36	37	-	-	B-NP	HYPH	I-cell_line	8	P	I-cell_line
O	O	O	37	40	937	937	I-NP	CD	I-cell_line	6	OBJ	I-cell_line
O	O	O	41	43	as	as	B-PP	IN	O	6	NMOD	O
O	O	O	44	45	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	46	51	model	model	I-NP	NN	O	9	PMOD	O
O	O	O	52	55	for	for	B-PP	IN	O	11	NMOD	O
O	O	O	56	64	studying	study	B-VP	VBG	O	12	PMOD	O
O	O	O	65	76	alterations	alteration	B-NP	NNS	O	13	OBJ	O
O	O	O	77	79	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	80	87	steroid	steroid	B-NP	NN	O	21	NMOD	O
O	O	O	87	88	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	O	88	95	induced	induce	I-NP	VBN	O	21	NMOD	O
T10	B-Entity	B-Entity	96	104	monokine	monokine	I-NP	NN	O	21	NMOD	O
T10	I-Entity	I-Entity	105	109	gene	gene	I-NP	NN	O	21	NMOD	O
O	O	O	110	120	expression	expression	I-NP	NN	O	15	PMOD	O
O	O	O	120	121	:	:	O	:	O	6	P	O
O	O	O	122	128	marked	marked	B-NP	JJ	O	24	NMOD	O
O	O	O	129	140	enhancement	enhancement	I-NP	NN	O	0	ROOT	O
O	O	O	141	143	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	144	162	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	34	NMOD	O
O	O	O	162	163	-	-	B-NP	HYPH	O	34	P	O
O	O	O	163	173	stimulated	stimulate	I-NP	VBN	O	29	NMOD	O
T1	B-Protein	B-Protein	174	185	interleukin	interleukin	I-NP	NN	B-protein	34	NMOD	B-protein
T1	I-Protein	I-Protein	185	186	-	-	O	HYPH	O	34	P	O
T1	I-Protein	I-Protein	186	187	1	1	B-NP	CD	B-RNA	34	NMOD	B-RNA
T1	I-Protein	I-Protein	188	192	beta	beta	I-NP	SYM	I-RNA	34	NMOD	I-RNA
O	O	O	193	202	messenger	messenger	I-NP	NN	I-RNA	34	NMOD	I-RNA
O	O	O	203	206	RNA	RNA	I-NP	NN	I-RNA	35	NMOD	I-RNA
O	O	O	207	213	levels	level	I-NP	NNS	O	25	PMOD	O
O	O	O	214	216	by	by	B-PP	IN	O	24	NMOD	O
O	O	O	217	218	1	1	B-NP	CD	O	42	NMOD	O
O	O	O	218	219	,	,	I-NP	,	O	42	P	O
O	O	O	219	221	25	25	I-NP	CD	O	42	NMOD	O
O	O	O	221	222	-	-	I-NP	HYPH	O	42	NMOD	O
O	O	O	222	238	dihydroxyvitamin	dihydroxyvitamin	I-NP	NN	O	42	NMOD	O
O	O	O	239	241	D3	D3	I-NP	NN	O	36	PMOD	O
O	O	O	241	242	.	.	O	.	O	24	P	O

O	O	O	244	247	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	248	254	active	active	I-NP	JJ	O	3	NMOD	O
O	O	O	255	265	metabolite	metabolite	I-NP	NN	O	25	SUB	O
O	O	O	266	268	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	269	276	vitamin	vitamin	B-NP	NN	O	6	NMOD	O
O	O	O	277	278	D	D	I-NP	NN	O	13	NMOD	O
O	O	O	278	279	,	,	O	,	O	13	P	O
O	O	O	280	281	1	1	B-NP	CD	O	13	NMOD	O
O	O	O	281	282	,	,	I-NP	,	O	13	P	O
O	O	O	282	284	25	25	I-NP	CD	O	13	NMOD	O
O	O	O	284	285	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	285	301	dihydroxyvitamin	dihydroxyvitamin	I-NP	NN	O	13	NMOD	O
O	O	O	302	304	D3	D3	I-NP	NN	O	4	PMOD	O
O	O	O	305	306	[	[	I-NP	(	O	23	DEP	O
O	O	O	306	307	1	1	I-NP	CD	O	22	NMOD	O
O	O	O	307	308	,	,	I-NP	,	O	22	P	O
O	O	O	308	310	25	25	I-NP	CD	O	22	NMOD	O
O	O	O	310	311	-	-	O	HYPH	O	21	P	O
O	O	O	311	312	(	(	O	(	O	21	DEP	O
O	O	O	312	314	OH	OH	B-NP	NN	O	21	DEP	O
O	O	O	314	315	)	)	O	)	O	17	NMOD	O
O	O	O	315	318	2D3	2D3	B-NP	NN	O	23	DEP	O
O	O	O	318	319	]	]	O	)	O	13	NMOD	O
O	O	O	319	320	,	,	O	,	O	3	P	O
O	O	O	321	323	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	324	325	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	326	332	potent	potent	I-NP	JJ	O	28	NMOD	O
O	O	O	333	342	regulator	regulator	I-NP	NN	O	25	PRD	O
O	O	O	343	345	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	346	351	human	human	B-NP	JJ	B-cell_type	34	NMOD	B-cell_type
O	O	O	352	360	monocyte	monocyte	I-NP	NN	I-cell_type	34	NMOD	I-cell_type
O	O	O	360	361	/	/	B-VP	SYM	O	34	P	O
O	O	O	361	371	macrophage	macrophage	B-NP	NN	O	34	NMOD	O
O	O	O	372	380	function	function	I-NP	NN	O	29	PMOD	O
O	O	O	381	383	in	in	B-ADVP	FW	O	25	VMOD	O
O	O	O	384	389	vitro	vitro	I-ADVP	FW	O	35	AMOD	O
O	O	O	389	390	.	.	O	.	O	25	P	O

O	O	O	391	393	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	394	403	establish	establish	I-VP	VB	O	0	ROOT	O
O	O	O	404	405	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	406	411	model	model	I-NP	NN	O	2	OBJ	O
O	O	O	412	415	for	for	B-PP	IN	O	4	NMOD	O
O	O	O	416	417	1	1	B-NP	CD	O	8	NMOD	O
O	O	O	417	418	,	,	I-NP	,	O	8	P	O
O	O	O	418	420	25	25	I-NP	CD	O	14	NMOD	O
O	O	O	420	421	-	-	O	HYPH	O	12	P	O
O	O	O	421	422	(	(	O	(	O	12	DEP	O
O	O	O	422	424	OH	OH	B-NP	NN	O	12	DEP	O
O	O	O	424	425	)	)	O	)	O	8	NMOD	O
O	O	O	425	428	2D3	2D3	B-NP	NN	O	14	NMOD	O
O	O	O	429	439	regulation	regulation	I-NP	NN	O	39	SUB	O
O	O	O	440	442	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	443	448	human	human	B-NP	JJ	O	19	NMOD	O
O	O	O	449	457	monocyte	monocyte	I-NP	NN	O	19	NMOD	O
O	O	O	458	466	monokine	monokine	I-NP	NN	O	19	NMOD	O
O	O	O	467	476	synthesis	synthesis	I-NP	NN	O	15	PMOD	O
O	O	O	476	477	,	,	O	,	O	39	P	O
O	O	O	478	483	three	three	B-NP	CD	O	39	SUB	O
O	O	O	484	489	human	human	I-NP	JJ	B-cell_line	24	NMOD	B-cell_line
O	O	O	490	494	cell	cell	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	495	500	lines	line	I-NP	NNS	I-cell_line	21	NMOD	I-cell_line
O	O	O	501	502	(	(	O	(	O	38	DEP	O
O	O	O	502	503	U	U	B-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	O	503	504	-	-	O	HYPH	I-cell_line	28	P	I-cell_line
O	O	O	504	507	937	937	B-NP	CD	I-cell_line	37	NMOD	I-cell_line
O	O	O	507	508	,	,	O	,	O	37	P	O
O	O	O	509	512	THP	THP	B-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	O	512	513	-	-	B-NP	HYPH	I-cell_line	37	NMOD	I-cell_line
O	O	O	513	514	1	1	I-NP	CD	I-cell_line	31	NMOD	I-cell_line
O	O	O	514	515	,	,	O	,	O	37	P	O
O	O	O	516	519	and	and	O	CC	O	37	NMOD	O
O	O	O	520	522	HL	HL	B-NP	NN	B-cell_line	37	NMOD	B-cell_line
O	O	O	522	523	-	-	B-NP	HYPH	I-cell_line	37	P	I-cell_line
O	O	O	523	525	60	60	I-NP	CD	I-cell_line	38	DEP	I-cell_line
O	O	O	525	526	)	)	O	)	O	21	NMOD	O
O	O	O	527	531	were	be	B-VP	VBD	O	5	SBAR	O
O	O	O	532	540	examined	examine	I-VP	VBN	O	39	VC	O
O	O	O	541	544	for	for	B-PP	IN	O	40	VMOD	O
O	O	O	544	545	:	:	O	:	O	41	P	O
O	O	O	546	547	1	1	B-LST	LS	O	46	NMOD	O
O	O	O	547	548	)	)	O	)	O	43	DEP	O
O	O	O	549	552	the	the	B-NP	DT	O	46	NMOD	O
O	O	O	553	561	presence	presence	I-NP	NN	O	41	PMOD	O
O	O	O	562	564	of	of	B-PP	IN	O	46	NMOD	O
O	O	O	565	575	functional	functional	B-NP	JJ	O	47	PMOD	O
O	O	O	576	577	1	1	I-NP	CD	O	48	NMOD	O
O	O	O	577	578	,	,	I-NP	,	O	48	P	O
O	O	O	578	580	25	25	I-NP	CD	O	48	NMOD	O
O	O	O	580	581	-	-	O	HYPH	B-protein	57	NMOD	B-protein
O	O	O	581	582	(	(	O	(	I-protein	57	NMOD	I-protein
O	O	O	582	584	OH	OH	B-NP	NN	I-protein	57	NMOD	I-protein
O	O	O	584	585	)	)	O	)	I-protein	57	NMOD	I-protein
O	O	O	585	588	2D3	2D3	B-NP	NN	I-protein	57	NMOD	I-protein
O	O	O	589	598	receptors	receptor	I-NP	NNS	I-protein	48	NMOD	I-protein
O	O	O	598	599	;	;	O	:	O	2	VMOD	O
O	O	O	600	601	2	2	B-LST	LS	O	62	NMOD	O
O	O	O	601	602	)	)	O	)	O	59	DEP	O
O	O	O	603	606	the	the	B-NP	DT	O	62	NMOD	O
O	O	O	607	619	accumulation	accumulation	I-NP	NN	O	93	NMOD	O
O	O	O	620	622	of	of	B-PP	IN	O	62	NMOD	O
T2	B-Protein	B-Protein	623	634	interleukin	interleukin	B-NP	NN	B-RNA	80	NMOD	B-RNA
T2	I-Protein	I-Protein	634	635	-	-	O	HYPH	I-RNA	80	P	I-RNA
T2	I-Protein	I-Protein	635	636	1	1	B-NP	CD	I-RNA	67	NMOD	I-RNA
T2	I-Protein	I-Protein	637	641	beta	beta	I-NP	NN	I-RNA	80	NMOD	I-RNA
O	O	O	642	643	(	(	O	(	I-RNA	80	NMOD	I-RNA
T3	B-Protein	B-Protein	643	645	IL	IL	B-NP	NN	I-RNA	80	NMOD	I-RNA
T3	I-Protein	I-Protein	645	646	-	-	O	HYPH	I-RNA	69	P	I-RNA
T3	I-Protein	I-Protein	646	647	1	1	O	CD	I-RNA	80	NMOD	I-RNA
T3	I-Protein	I-Protein	648	652	beta	beta	O	SYM	I-RNA	73	DEP	I-RNA
O	O	O	652	653	)	)	O	)	I-RNA	80	NMOD	I-RNA
O	O	O	654	658	mRNA	mRNA	B-NP	NN	I-RNA	80	NMOD	I-RNA
O	O	O	659	662	and	and	I-NP	CC	O	80	NMOD	O
T4	B-Protein	B-Protein	663	665	IL	IL	I-NP	NN	B-protein	80	NMOD	B-protein
T4	I-Protein	I-Protein	665	666	-	-	O	HYPH	I-protein	80	P	I-protein
T4	I-Protein	I-Protein	666	667	1	1	B-NP	CD	I-protein	80	NMOD	I-protein
T4	I-Protein	I-Protein	668	672	beta	beta	I-NP	SYM	I-protein	80	NMOD	I-protein
O	O	O	673	680	protein	protein	I-NP	NN	I-protein	63	PMOD	I-protein
O	O	O	681	683	in	in	B-PP	IN	O	62	NMOD	O
O	O	O	684	692	response	response	I-PP	NN	O	81	PMOD	O
O	O	O	693	695	to	to	I-PP	TO	O	82	NMOD	O
O	O	O	696	714	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	83	PMOD	O
O	O	O	715	716	(	(	O	(	O	87	DEP	O
O	O	O	716	719	LPS	LPS	B-NP	NN	O	87	DEP	O
O	O	O	719	720	)	)	O	)	O	84	NMOD	O
O	O	O	720	721	;	;	O	:	O	93	P	O
O	O	O	722	725	and	and	O	CC	O	93	NMOD	O
O	O	O	726	727	3	3	B-LST	LS	O	93	NMOD	O
O	O	O	727	728	)	)	O	)	O	90	DEP	O
O	O	O	729	732	the	the	B-NP	DT	O	93	NMOD	O
O	O	O	733	743	regulation	regulation	I-NP	NN	O	58	PMOD	O
O	O	O	744	746	of	of	B-PP	IN	O	93	NMOD	O
O	O	O	747	751	this	this	B-NP	DT	O	96	NMOD	O
O	O	O	752	760	response	response	I-NP	NN	O	94	PMOD	O
O	O	O	761	763	by	by	B-PP	IN	O	93	NMOD	O
O	O	O	764	765	1	1	B-NP	CD	O	100	NMOD	O
O	O	O	765	766	,	,	I-NP	,	O	100	P	O
O	O	O	766	768	25	25	I-NP	CD	O	105	NMOD	O
O	O	O	768	769	-	-	O	HYPH	O	104	P	O
O	O	O	769	770	(	(	O	(	O	104	DEP	O
O	O	O	770	772	OH	OH	B-NP	NN	O	104	DEP	O
O	O	O	772	773	)	)	O	)	O	100	NMOD	O
O	O	O	773	776	2D3	2D3	B-NP	NN	O	97	PMOD	O
O	O	O	776	777	.	.	O	.	O	2	P	O

O	O	O	778	781	All	All	B-NP	DT	O	4	NMOD	O
O	O	O	782	787	three	three	I-NP	CD	O	4	NMOD	O
O	O	O	788	792	cell	cell	I-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	793	798	lines	line	I-NP	NNS	I-cell_line	5	SUB	I-cell_line
O	O	O	799	808	expressed	express	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	B-Protein	809	816	vitamin	vitamin	B-NP	NN	B-protein	8	NMOD	B-protein
T5	I-Protein	I-Protein	817	818	D	D	I-NP	NN	I-protein	8	NMOD	I-protein
T5	I-Protein	I-Protein	819	827	receptor	receptor	I-NP	NN	I-protein	5	OBJ	I-protein
O	O	O	828	831	and	and	O	CC	O	5	VMOD	O
O	O	O	832	835	had	have	B-VP	VBD	O	5	VMOD	O
O	O	O	836	845	increased	increase	I-VP	VBN	O	10	VC	O
O	O	O	846	852	levels	level	B-NP	NNS	O	11	OBJ	O
O	O	O	853	855	of	of	B-PP	IN	O	12	NMOD	O
T6	B-Protein	B-Protein	856	858	IL	IL	B-NP	NN	B-RNA	18	NMOD	B-RNA
T6	I-Protein	I-Protein	858	859	-	-	O	HYPH	I-RNA	18	P	I-RNA
T6	I-Protein	I-Protein	859	860	1	1	B-NP	CD	I-RNA	18	NMOD	I-RNA
T6	I-Protein	I-Protein	861	865	beta	beta	I-NP	SYM	I-RNA	18	NMOD	I-RNA
O	O	O	866	870	mRNA	mRNA	I-NP	NN	I-RNA	13	PMOD	I-RNA
O	O	O	871	873	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	874	882	response	response	I-PP	NN	O	19	PMOD	O
O	O	O	883	885	to	to	I-PP	TO	O	20	NMOD	O
O	O	O	886	889	LPS	LPS	B-NP	NN	O	21	PMOD	O
O	O	O	889	890	.	.	O	.	O	5	P	O

O	O	O	891	904	Preincubation	Preincubation	B-NP	NN	O	13	SUB	O
O	O	O	905	907	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	908	913	cells	cell	B-NP	NNS	O	2	PMOD	O
O	O	O	914	918	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	919	920	1	1	B-NP	CD	O	7	NMOD	O
O	O	O	920	921	,	,	I-NP	,	O	7	P	O
O	O	O	921	923	25	25	I-NP	CD	O	12	NMOD	O
O	O	O	923	924	-	-	O	HYPH	O	11	P	O
O	O	O	924	925	(	(	O	(	O	11	DEP	O
O	O	O	925	927	OH	OH	B-NP	NN	O	11	DEP	O
O	O	O	927	928	)	)	O	)	O	7	NMOD	O
O	O	O	928	931	2D3	2D3	B-NP	NN	O	4	PMOD	O
O	O	O	932	941	augmented	augment	B-VP	VBD	O	0	ROOT	O
T7	B-Protein	B-Protein	942	944	IL	IL	B-NP	NN	B-RNA	18	NMOD	B-RNA
T7	I-Protein	I-Protein	944	945	-	-	O	HYPH	I-RNA	18	P	I-RNA
T7	I-Protein	I-Protein	945	946	1	1	B-NP	CD	I-RNA	18	NMOD	I-RNA
T7	I-Protein	I-Protein	947	951	beta	beta	I-NP	SYM	I-RNA	18	NMOD	I-RNA
O	O	O	952	956	mRNA	mRNA	I-NP	NN	I-RNA	19	NMOD	I-RNA
O	O	O	957	963	levels	level	I-NP	NNS	O	13	OBJ	O
O	O	O	964	968	only	only	B-ADVP	RB	O	21	PMOD	O
O	O	O	969	971	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	972	973	U	U	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	O	973	974	-	-	B-NP	HYPH	I-cell_line	29	P	I-cell_line
O	O	O	974	977	937	937	I-NP	CD	I-cell_line	29	NMOD	I-cell_line
O	O	O	978	981	and	and	I-NP	CC	O	29	NMOD	O
O	O	O	982	984	HL	HL	I-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	O	984	985	-	-	O	HYPH	I-cell_line	29	NMOD	I-cell_line
O	O	O	985	987	60	60	B-NP	CD	I-cell_line	29	NMOD	I-cell_line
O	O	O	988	993	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	993	994	.	.	O	.	O	13	P	O

O	O	O	995	999	From	From	B-PP	IN	O	22	VMOD	O
O	O	O	1000	1005	these	these	B-NP	DT	O	3	NMOD	O
O	O	O	1006	1010	data	datum	I-NP	NNS	O	1	PMOD	O
O	O	O	1010	1011	,	,	O	,	O	1	P	O
O	O	O	1012	1015	and	and	O	CC	O	1	DEP	O
O	O	O	1016	1022	taking	take	B-VP	VBG	O	1	DEP	O
O	O	O	1023	1027	into	into	B-PP	IN	O	6	VMOD	O
O	O	O	1028	1041	consideration	consideration	B-NP	NN	O	7	PMOD	O
O	O	O	1042	1047	their	their	B-NP	PRP$	O	10	NMOD	O
O	O	O	1048	1053	state	state	B-NP	NN	O	15	NMOD	O
O	O	O	1054	1056	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1057	1072	differentiation	differentiation	B-NP	NN	O	11	PMOD	O
O	O	O	1073	1076	and	and	O	CC	O	15	NMOD	O
O	O	O	1077	1085	relative	relative	B-NP	JJ	O	15	NMOD	O
O	O	O	1086	1090	ease	ease	I-NP	NN	O	6	OBJ	O
O	O	O	1091	1093	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1094	1101	culture	culture	B-NP	NN	O	16	PMOD	O
O	O	O	1101	1102	,	,	O	,	O	22	P	O
O	O	O	1103	1104	U	U	B-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	O	1104	1105	-	-	O	HYPH	I-cell_line	21	P	I-cell_line
O	O	O	1105	1108	937	937	B-NP	CD	I-cell_line	22	SUB	I-cell_line
O	O	O	1109	1112	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1113	1119	chosen	choose	I-VP	VBN	O	22	VC	O
O	O	O	1120	1124	over	over	B-PP	IN	O	23	VMOD	O
O	O	O	1125	1127	HL	HL	B-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	O	1127	1128	-	-	B-NP	HYPH	I-cell_line	31	P	I-cell_line
O	O	O	1128	1130	60	60	I-NP	CD	I-cell_line	31	NMOD	I-cell_line
O	O	O	1131	1134	and	and	I-NP	CC	O	31	NMOD	O
O	O	O	1135	1138	THP	THP	I-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	O	1138	1139	-	-	B-NP	HYPH	I-cell_line	31	P	I-cell_line
O	O	O	1139	1140	1	1	I-NP	CD	I-cell_line	24	PMOD	I-cell_line
O	O	O	1141	1143	as	as	B-PP	IN	O	31	NMOD	O
O	O	O	1144	1147	the	the	B-NP	DT	O	35	NMOD	O
O	O	O	1148	1152	cell	cell	I-NP	NN	B-cell_line	35	NMOD	B-cell_line
O	O	O	1153	1157	line	line	I-NP	NN	I-cell_line	32	PMOD	I-cell_line
O	O	O	1158	1160	we	we	B-NP	PRP	O	37	SUB	O
O	O	O	1161	1168	further	further	B-VP	RBR	O	38	VMOD	O
O	O	O	1169	1182	characterized	characterize	I-VP	VBN	O	22	VC	O
O	O	O	1182	1183	.	.	O	.	O	22	P	O

O	O	O	1184	1186	In	In	B-PP	IN	O	22	VMOD	O
O	O	O	1187	1188	U	U	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	O	1188	1189	-	-	O	HYPH	I-cell_line	5	NMOD	I-cell_line
O	O	O	1189	1192	937	937	B-NP	CD	I-cell_line	5	NMOD	I-cell_line
O	O	O	1193	1198	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	1198	1199	,	,	O	,	O	22	P	O
O	O	O	1200	1207	optimum	optimum	B-NP	JJ	O	22	SUB	O
O	O	O	1208	1212	time	time	I-NP	NN	O	10	NMOD	O
O	O	O	1213	1216	and	and	O	CC	O	10	NMOD	O
O	O	O	1217	1221	dose	dose	B-NP	NN	O	7	NMOD	O
O	O	O	1222	1224	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1225	1237	pretreatment	pretreatment	B-NP	NN	O	11	PMOD	O
O	O	O	1238	1242	with	with	B-PP	IN	O	12	NMOD	O
O	O	O	1243	1244	1	1	B-NP	CD	O	16	NMOD	O
O	O	O	1244	1245	,	,	I-NP	,	O	16	P	O
O	O	O	1245	1247	25	25	I-NP	CD	O	21	NMOD	O
O	O	O	1247	1248	-	-	O	HYPH	O	20	P	O
O	O	O	1248	1249	(	(	O	(	O	20	DEP	O
O	O	O	1249	1251	OH	OH	B-NP	NN	O	20	DEP	O
O	O	O	1251	1252	)	)	O	)	O	16	NMOD	O
O	O	O	1252	1255	2D3	2D3	B-NP	NN	O	13	PMOD	O
O	O	O	1256	1260	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1261	1271	determined	determine	I-VP	VBN	O	22	VC	O
O	O	O	1272	1274	to	to	I-VP	TO	O	25	VMOD	O
O	O	O	1275	1277	be	be	I-VP	VB	O	23	VMOD	O
O	O	O	1278	1280	12	12	B-NP	CD	O	29	NMOD	O
O	O	O	1280	1281	-	-	I-NP	HYPH	O	29	NMOD	O
O	O	O	1281	1283	24	24	I-NP	CD	O	29	NMOD	O
O	O	O	1284	1285	h	h	I-NP	NN	O	25	PRD	O
O	O	O	1286	1288	at	at	B-PP	IN	O	25	VMOD	O
O	O	O	1289	1290	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	1291	1299	receptor	receptor	I-NP	NN	O	34	NMOD	O
O	O	O	1300	1310	saturating	saturate	B-VP	VBG	O	34	NMOD	O
O	O	O	1311	1324	concentration	concentration	B-NP	NN	O	43	NMOD	O
O	O	O	1325	1327	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	1328	1329	1	1	B-NP	CD	O	38	NMOD	O
O	O	O	1329	1330	,	,	I-NP	,	O	38	P	O
O	O	O	1330	1332	25	25	I-NP	CD	O	35	PMOD	O
O	O	O	1332	1333	-	-	O	HYPH	O	34	P	O
O	O	O	1333	1334	(	(	O	(	O	42	DEP	O
O	O	O	1334	1336	OH	OH	B-NP	NN	O	42	DEP	O
O	O	O	1336	1337	)	)	O	)	O	34	NMOD	O
O	O	O	1337	1340	2D3	2D3	B-NP	NN	O	30	PMOD	O
O	O	O	1341	1342	(	(	O	(	O	47	DEP	O
O	O	O	1342	1344	10	10	B-NP	CD	O	46	NMOD	O
O	O	O	1345	1347	nM	nM	I-NP	NN	O	47	DEP	O
O	O	O	1347	1348	)	)	O	)	O	43	NMOD	O
O	O	O	1348	1349	.	.	O	.	O	22	P	O

O	O	O	1350	1363	Preincubation	Preincubation	B-NP	NN	O	13	SUB	O
O	O	O	1364	1366	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1367	1372	cells	cell	B-NP	NNS	O	2	PMOD	O
O	O	O	1373	1377	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	1378	1379	1	1	B-NP	CD	O	7	NMOD	O
O	O	O	1379	1380	,	,	I-NP	,	O	7	P	O
O	O	O	1380	1382	25	25	I-NP	CD	O	12	NMOD	O
O	O	O	1382	1383	-	-	O	HYPH	O	11	P	O
O	O	O	1383	1384	(	(	O	(	O	11	DEP	O
O	O	O	1384	1386	OH	OH	B-NP	NN	O	11	DEP	O
O	O	O	1386	1387	)	)	O	)	O	7	NMOD	O
O	O	O	1387	1390	2D3	2D3	B-NP	NN	O	4	PMOD	O
O	O	O	1391	1394	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	1395	1397	no	no	B-NP	DT	O	15	NMOD	O
O	O	O	1398	1404	effect	effect	I-NP	NN	O	13	OBJ	O
O	O	O	1405	1407	on	on	B-PP	IN	O	13	VMOD	O
O	O	O	1408	1411	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1412	1416	time	time	I-NP	NN	O	19	NMOD	O
O	O	O	1417	1423	course	course	I-NP	NN	O	16	PMOD	O
O	O	O	1424	1426	of	of	B-PP	IN	O	19	NMOD	O
T8	B-Protein	B-Protein	1427	1429	IL	IL	B-NP	NN	B-RNA	26	NMOD	B-RNA
T8	I-Protein	I-Protein	1429	1430	-	-	O	HYPH	I-RNA	26	P	I-RNA
T8	I-Protein	I-Protein	1430	1431	1	1	B-NP	CD	I-RNA	25	NMOD	I-RNA
T8	I-Protein	I-Protein	1432	1436	beta	beta	I-NP	SYM	I-RNA	25	NMOD	I-RNA
O	O	O	1437	1441	mRNA	mRNA	I-NP	NN	I-RNA	26	NMOD	I-RNA
O	O	O	1442	1452	appearance	appearance	I-NP	NN	O	20	PMOD	O
O	O	O	1453	1455	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	1456	1464	response	response	I-PP	NN	O	27	PMOD	O
O	O	O	1465	1467	to	to	I-PP	TO	O	28	NMOD	O
O	O	O	1468	1471	LPS	LPS	B-NP	NN	O	29	PMOD	O
O	O	O	1471	1472	.	.	O	.	O	13	P	O

O	O	O	1473	1480	However	However	B-ADVP	RB	O	18	VMOD	O
O	O	O	1480	1481	,	,	O	,	O	18	P	O
O	O	O	1482	1490	exposure	exposure	B-NP	NN	O	17	NMOD	O
O	O	O	1491	1493	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1494	1495	U	U	B-NP	NN	B-cell_line	8	NMOD	B-cell_line
O	O	O	1495	1496	-	-	O	HYPH	I-cell_line	8	NMOD	I-cell_line
O	O	O	1496	1499	937	937	B-NP	CD	I-cell_line	8	NMOD	I-cell_line
O	O	O	1500	1505	cells	cell	I-NP	NNS	I-cell_line	4	PMOD	I-cell_line
O	O	O	1506	1508	to	to	B-PP	TO	O	3	NMOD	O
O	O	O	1509	1510	1	1	B-NP	CD	O	12	NMOD	O
O	O	O	1510	1511	,	,	I-NP	,	O	12	P	O
O	O	O	1511	1513	25	25	I-NP	CD	O	9	PMOD	O
O	O	O	1513	1514	-	-	O	HYPH	O	3	P	O
O	O	O	1514	1515	(	(	O	(	O	16	DEP	O
O	O	O	1515	1517	OH	OH	B-NP	NN	O	16	DEP	O
O	O	O	1517	1518	)	)	O	)	O	3	NMOD	O
O	O	O	1518	1521	2D3	2D3	B-NP	NN	O	18	SUB	O
O	O	O	1522	1531	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	1532	1534	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	1535	1538	200	200	B-NP	CD	O	21	NMOD	O
O	O	O	1538	1539	%	%	I-NP	NN	O	19	PMOD	O
O	O	O	1540	1543	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1544	1549	level	level	I-NP	NN	O	66	NMOD	O
O	O	O	1550	1552	of	of	B-PP	IN	O	23	NMOD	O
T9	B-Protein	B-Protein	1553	1555	IL	IL	B-NP	NN	B-RNA	29	NMOD	B-RNA
T9	I-Protein	I-Protein	1555	1556	-	-	O	HYPH	I-RNA	29	NMOD	I-RNA
T9	I-Protein	I-Protein	1556	1557	1	1	B-NP	CD	I-RNA	29	NMOD	I-RNA
T9	I-Protein	I-Protein	1558	1562	beta	beta	I-NP	SYM	I-RNA	29	NMOD	I-RNA
O	O	O	1563	1567	mRNA	mRNA	I-NP	NN	I-RNA	24	PMOD	I-RNA
O	O	O	1568	1576	detected	detect	B-VP	VBN	O	29	NMOD	O
O	O	O	1577	1580	and	and	I-VP	CC	O	30	VMOD	O
O	O	O	1581	1590	decreased	decrease	I-VP	VBN	O	30	VMOD	O
O	O	O	1591	1593	by	by	B-PP	IN	O	32	VMOD	O
O	O	O	1594	1599	three	three	B-NP	CD	O	35	NMOD	O
O	O	O	1600	1606	orders	order	I-NP	NNS	O	33	PMOD	O
O	O	O	1607	1609	of	of	B-PP	IN	O	35	NMOD	O
O	O	O	1610	1619	magnitude	magnitude	B-NP	NN	O	36	PMOD	O
O	O	O	1620	1623	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	1624	1637	concentration	concentration	I-NP	NN	O	32	VMOD	O
O	O	O	1638	1640	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	1641	1644	LPS	LPS	B-NP	NN	O	40	PMOD	O
O	O	O	1645	1653	required	require	B-VP	VBN	O	39	NMOD	O
O	O	O	1654	1656	to	to	I-VP	TO	O	44	VMOD	O
O	O	O	1657	1664	achieve	achieve	I-VP	VB	O	42	VMOD	O
O	O	O	1665	1671	steady	steady	B-NP	JJ	O	48	NMOD	O
O	O	O	1672	1677	state	state	I-NP	NN	O	48	NMOD	O
O	O	O	1678	1682	mRNA	mRNA	I-NP	NN	O	48	NMOD	O
O	O	O	1683	1689	levels	level	I-NP	NNS	O	44	OBJ	O
O	O	O	1690	1700	equivalent	equivalent	B-ADJP	JJ	O	48	NMOD	O
O	O	O	1701	1703	to	to	B-PP	TO	O	49	AMOD	O
O	O	O	1704	1709	those	those	B-NP	DT	O	50	PMOD	O
O	O	O	1710	1718	observed	observe	B-VP	VBN	O	51	NMOD	O
O	O	O	1719	1721	in	in	B-PP	IN	O	52	VMOD	O
O	O	O	1722	1723	U	U	B-NP	NN	B-cell_line	57	NMOD	B-cell_line
O	O	O	1723	1724	-	-	O	HYPH	I-cell_line	57	NMOD	I-cell_line
O	O	O	1724	1727	937	937	B-NP	CD	I-cell_line	57	NMOD	I-cell_line
O	O	O	1728	1733	cells	cell	I-NP	NNS	I-cell_line	53	PMOD	I-cell_line
O	O	O	1734	1737	not	not	B-VP	RB	O	59	VMOD	O
O	O	O	1738	1750	preincubated	preincubate	I-VP	VBN	O	57	NMOD	O
O	O	O	1751	1755	with	with	B-PP	IN	O	59	VMOD	O
O	O	O	1756	1759	the	the	B-NP	DT	O	62	NMOD	O
O	O	O	1760	1767	hormone	hormone	I-NP	NN	O	60	PMOD	O
O	O	O	1767	1768	.	.	O	.	O	66	P	O
O	O	O	1768	1769	2	2	B-NP	CD	O	66	NMOD	O
O	O	O	1769	1770	+	+	I-NP	SYM	O	66	NMOD	O
O	O	O	1770	1771	o	o	I-NP	NN	O	18	VMOD	O
